Helix
Helix is a population genomics company that is working to advance genomics research and integrate genomic data into clinical care.
About Helix
Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world's largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+™ assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.
Company Facts
- Headquarters
- San Mateo
- Founded
- 2015
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- private
- Employees
- c_00101_00250
- Funding Stage
- late_stage_venture
- Total Funding
- $403,000,000
- Last Funding Type
- series_c
- Last Funding Date
- 2021-06-03
- Website
- helix.com
Industries & Categories
Big Data, Bioinformatics, Biotechnology, Blockchain, Cryptocurrency, FinTech, Genetics, Health Care, Personal Health
Social Links
Canonical: https://fsome.com/organization/helix-49199 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.